Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 4/2011

01-08-2011 | Case Report

Pneumatosis cystoides intestinalis in neuropsychiatric systemic lupus erythematosus with diabetes mellitus: case report and literature review

Authors: Yasuhiro Shimojima, Wataru Ishii, Masayuki Matsuda, Kana Tojo, Rie Watanabe, Shu-ichi Ikeda

Published in: Modern Rheumatology | Issue 4/2011

Login to get access

Abstract

We report a patient with neuropsychiatric systemic lupus erythematosus (NPSLE) complicated by diabetes mellitus (DM) who showed pneumatosis cystoides intestinalis (PCI) while being treated with prednisolone (PSL) and an alpha-glucosidase inhibitor (αGI). The PCI was ameliorated with the cessation of the αGI and tapering of PSL in addition to transient fasting. Multiple factors, including NPSLE, DM, and medications, may have been involved in the pathogenesis of PCI in this patient.
Literature
1.
Heng Y, Schuffler MD, Haggitt RC, Rohrmann CA. Pneumatosis intestinalis: a review. Am J Gastroenterol. 1995;90:1747–58.PubMed
2.
Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2008;53:1163–74.PubMedCrossRef
3.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.PubMedCrossRef
4.
ACR Ad Hoc Committee on neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.CrossRef
5.
Stafford-Brady FJ, Kahn HJ, Ross TM, Russell ML. Advanced scleroderma bowel: complications and management. J Rheumatol. 1988;15:869–74.PubMed
6.
Buffo GC, Deitch JS. Pneumatosis intestinalis in a patient with polyarteritis nodosa. Gastrointest Radiol. 1986;11:286–8.PubMedCrossRef
7.
Pasquier E, Wattiaux MJ, Peigney N. First case of pneumatosis cystoides intestinalis in adult dermatomyositis. J Rheumatol. 1993;20:499–503.PubMed
8.
Gamez-Nava JI, Gonzalez-Lopez L, Ramos-Remus C, Fonseca-Gomez MM, Cardona-Muñoz EG, Suarez-Almazor ME. Autonomic dysfunction in patients with systemic lupus erythematosus. J Rheumatol. 1998;25:1092–6.PubMed
9.
Yukawa S, Tahara K, Shoji A, Hayashi H, Tsuboi N. Acute pan-dysautonomia as well as central nervous system involvement and peripheral neuropathies in a patient with systemic lupus erythematosus. Mod Rheumatol. 2008;18:516–21.PubMedCrossRef
10.
Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.PubMedCrossRef
11.
Freiman D, Chon H, Bilaniuk L. Pneumatosis intestinalis in systemic erythematosus. Radiology. 1975;116:563–4.PubMed
12.
Morrison WJ, Siegelman SS. Pneumatosis intestinalis in association with connective tissue disease. South Med J. 1976;69:1536–9.PubMedCrossRef
13.
Kleinman P, Meyers MA, Abbott G, Kazam E. Necrotizing enterocolitis with pneumatosis intestinalis in systemic lupus erythematosus and polyarteritis. Radiology. 1976;121:595–8.PubMed
14.
Binstadt DH, L’Heureux PR. Case report: pneumatosis cystoides intestinalis in childhood systemic lupus erythematosus. Minn Med. 1977;60:408–9.PubMed
15.
Derksen OS. Pneumatosis intestinalis in a female patient with systemic lupus erythematosus. Radiol Clin (Basel). 1978;47:334–9.
16.
Pruitt RE, Tumminello VV, Reveille JD. Pneumatosis cystoides intestinalis and benign pneumoperitoneum in a patient with antinuclear antibody negative systemic lupus erythematosus. J Rheumatol. 1988;15:1575–7.PubMed
17.
Laing TJ. Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide. Am J Med. 1988;85:555–8.PubMedCrossRef
18.
Decrop E, Ponette E, Baert AL, Verberckmoes R, Kerremens R, Geboes K. Pre-operative radiological diagnosis of acute necrotizing enteritis in systemic lupus erythematodes. J Belge Radiol. 1990;73:31–5.PubMed
19.
Atsumi T, Sagawa A, Watanabe I, Amasaki Y, Katsumata K, Nakabayashi T, et al. Pneumoperitoneum without perforation of the gastrointestinal tract in a patient with systemic lupus erythematosus. Ryumachi. 1991;31:398–404 (in Japanese).
20.
Cabrera GE, Scopelitis E, Cuellar ML, Silveira LH, Mena H, Espinoza LR. Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone. Clin Rheumatol. 1994;13:312–6.PubMed
21.
Nonaka D, Higuchi M, Yoshizawa S, Horiuchi T, Nakashima H, Niho Y. Pneumatosis cystoides intestinalis associated with intravenous pulse cyclophosphamide treatment for systemic lupus erythematosus. Ryumachi. 1998;38:605–10 (in Japanese).
22.
Hiraishi T, Tokuda M, Mitsunaka H, Dobashi H, Takahara J. Asymptomatic pneumatosis cystoides intestinalis in a patient with systemic lupus erythematosus. Ryumachi. 1999;39:580–5 (in Japanese).
23.
Alcocer-Gouyonnet F, Chan-Nuñez C, Hernández J, Guzmán J, Gamboa-Domínguez A. Acute abdomen and lupus enteritis: thrombocytopenia and pneumatosis intestinalis as indicators for surgery. Am Surg. 2000;66:193–5.PubMed
24.
Yamaguchi Y, Ohno S, Yamazaki S, Ideguchi H, Shirai A, Takeno M, et al. A case of systemic lupus erythematosus complicated with pneumatosis cystoides intestinalis. Mod Rheumatol. 2005;15:440–4.PubMedCrossRef
25.
Mizoguchi F, Nanki T, Miyasaka N. Pneumatosis cystoides intestinalis following lupus enteritis and peritonitis. Intern Med. 2008;47:1267–71.PubMedCrossRef
26.
Dovrish Z, Arnson Y, Amital H, Zissin R. Pneumatosis intestinalis presenting in autoimmune diseases: a report of three patients. Ann N Y Acad Sci. 2009;1173:199–202.PubMedCrossRef
27.
Hall RR, Anagnostou A, Kanojia M, Zander A. Pneumatosis intestinalis associated with graft-versus-host disease of the intestinal tract. Transplant Proc. 1984;16:1666–8.PubMed
28.
Wada Y, Murayama N, Hirose S, In H, Kuroda T, Ito S, et al. A case of pneumatosis cystoides intestinalis in a patient with polymyositis and interstitial pneumonia. Mod Rheumatol. 2004;14:260–3.PubMedCrossRef
29.
Xiao T, Xu HH, Wu J, He CD, Chen HD. Case of pneumatosis cystoides intestinalis in adult dermatomyositis. J Dermatol. 2008;35:49–51.PubMedCrossRef
30.
Tsujimoto T, Shioyama E, Moriya K, Kawaratani H, Shirai Y, Toyohara M, et al. Pneumatosis cystoides intestinalis following alpha-glucosidase inhibitor treatment: a case report and review of the literature. World J Gastroenterol. 2008;14:6087–92.PubMedCrossRef
31.
Vogel Y, Buchner NJ, Szpakowski M, Tannapfel A, Henning BF. Pneumatosis cystoides intestinalis of the ascending colon related to acarbose treatment: a case report. J Med Case Reports. 2009;3:9216.PubMedCrossRef
32.
Hisamoto A, Mizushima T, Sato K, Haruta Y, Tanimoto Y, Tanimoto M, et al. Pneumatosis cystoides intestinalis after alpha-glucosidase inhibitor treatment in a patient with interstitial pneumonitis. Intern Med. 2006;45:73–6.PubMedCrossRef
33.
Maeda Y, Inaba N, Aoyagi M, Kanda E, Shiigai T. Fulminant pneumatosis intestinalis in a patient with diabetes mellitus and minimal change nephrotic syndrome. Intern Med. 2007;46:41–4.PubMedCrossRef
34.
Saito M, Tanikawa A, Nakasute K, Tanaka M, Nishikawa T. Additive contribution of multiple factors in the development of pneumatosis intestinalis: a case report and review of the literature. Clin Rheumatol. 2007;26:601–3.PubMedCrossRef
Metadata
Title
Pneumatosis cystoides intestinalis in neuropsychiatric systemic lupus erythematosus with diabetes mellitus: case report and literature review
Authors
Yasuhiro Shimojima
Wataru Ishii
Masayuki Matsuda
Kana Tojo
Rie Watanabe
Shu-ichi Ikeda
Publication date
01-08-2011
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 4/2011
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-010-0407-2

Other articles of this Issue 4/2011

Modern Rheumatology 4/2011 Go to the issue

Original Article

Impact of natural disasters on the functional and health status of patients with rheumatoid arthritis

Case Report

Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab

Original Article

Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index

Rapid Communication

The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis

Case Report

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis

Case Report

Systemic sclerosis presented as congestive heart failure: an autopsy case
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits